Upgrade to SI Premium - Free Trial

UBS Reiterates Buy on Medtronic (MDT) Following 1Q Report

August 26, 2016 8:55 AM
UBS reiterated a Buy rating on Medtronic, Inc. (NYSE: MDT), and raised the price target to $96.00 (from $92.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles